Related Experiment Video
Updated: Jun 14, 2026
08:21
Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans
Published on: July 21, 2023
Race, ethnicity, ancestry, and pharmacogenetics
1Duke University, Durham, NC, USA. thomas.urban@duke.edu
The Mount Sinai Journal of Medicine, New York
|March 24, 2010
Summary
Pharmacogenetics studies how genetic variations affect drug responses. While race and ethnicity have influenced discoveries, the focus is on individual genetics for personalized medicine, addressing potential disparities.
Area of Science:
- Pharmacology
- Genetics
- Population Health
Background:
- Pharmacogenetics investigates genetic influences on drug response.
- Concepts of race, ethnicity, and ancestry have historically shaped pharmacogenetic research.
- Understanding population-level drug response differences is crucial.
Purpose of the Study:
- To explore the relationship between race, ethnicity, ancestry, and pharmacogenetics.
- To provide examples of benefits and pitfalls of using racial or ethnic labels in genetic studies.
- To discuss the future of pharmacogenetics, including rare genetic variations and disparities.
Main Methods:
- Literature review and conceptual analysis.
- Examination of historical and current applications of racial/ethnic concepts in pharmacogenetics.
- Discussion of case examples and future research directions.
Main Results:
- Racial and ethnic labels have been historically significant but can be imprecise in pharmacogenetics.
- The focus is shifting towards individual genetic determinants for personalized therapy.
- Potential for rare genetic variations to explain disparities in pharmacogenetic discovery.
Conclusions:
- Pharmacogenetics aims for individualized drug therapy, moving beyond broad population labels.
- Careful consideration of race, ethnicity, and ancestry is needed to avoid pitfalls and ensure equity.
- Future research should address rare genetic variations to improve pharmacogenetic discovery and reduce disparities.
Related Concept Videos
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...